Free Trial

Silexion Therapeutics (SLXN) SEC Filings & 10K Form

Silexion Therapeutics logo
$0.80 0.00 (-0.55%)
Closing price 07/3/2025 03:42 PM Eastern
Extended Trading
$0.81 +0.01 (+0.62%)
As of 07/3/2025 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Silexion Therapeutics SEC Filings

DateFilerForm TypeView
06/26/2025
3:15 PM
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SCHEDULE 13D/A
06/23/2025
3:48 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEFA14A
06/16/2025
9:51 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEF 14A
05/29/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
05/29/2025
9:14 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
3:04 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
05/23/2025
4:00 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
8:20 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
4:01 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
05/13/2025
10:36 AM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G/A
05/12/2025
11:12 AM
CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G/A
05/06/2025
7:35 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
05/01/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/29/2025
3:10 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form AW
04/29/2025
3:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/29/2025
11:10 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
04/27/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/23/2025
3:28 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/23/2025
8:53 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:06 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/10/2025
3:09 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/01/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/01/2025
3:45 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
03/28/2025
7:30 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
3:42 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
6:27 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
03/14/2025
5:59 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
7:46 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:31 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/30/2025
8:26 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
7:56 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
11:19 AM
CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/21/2025
4:49 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/17/2025
5:56 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
5:44 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B4
01/15/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
01/15/2025
5:02 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
4:02 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1/A
01/14/2025
5:19 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1/A
01/14/2025
5:01 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
5:00 AM
Peled Amnon (Reporting)
Silexion Therapeutics (Issuer)
Silexion Therapeutics Corp (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
12/17/2024
6:08 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
5:01 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:41 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
12/10/2024
8:42 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
12/10/2024
7:48 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
5:00 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
5:05 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/29/2024
5:06 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/27/2024
5:01 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:30 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:32 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/20/2024
5:15 AM
Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SC 13D
11/14/2024
8:03 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:30 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:05 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
4:24 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/22/2024
8:02 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEF 14A
10/16/2024
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
10/16/2024
8:32 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
10/10/2024
4:00 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form PRE 14A
10/09/2024
5:04 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/01/2024
5:53 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
6:10 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:06 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
09/18/2024
3:32 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
09/17/2024
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
09/09/2024
6:33 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/09/2024
7:00 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:48 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/22/2024
5:44 PM
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SC 13D
08/22/2024
4:23 PM
Moringa Sponsor, LP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SC 13D
08/21/2024
3:45 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:38 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Lushi Avner (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:43 PM
Abramov Dror Yosef (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:47 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shiloah Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Hadar Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Horenshtein Hadar Mirit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shirvan Mitchell (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM
Alon Ruth (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:50 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Noy Shlomo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:54 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Levin Ilan (Reporting)
Moringa Sponsor, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
7:12 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Potter Leonard (Reporting)
Wildcat Capital Management, LLC (Reporting)
Wildcat Partner Holdings, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
2:22 PM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form CERT
08/15/2024
1:45 PM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form 8-A12B
07/25/2024
3:05 PM
Silexion Therapeutics (Filed by)
Biomotion Sciences (Filed by)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Form 425
07/25/2024
3:05 PM
Silexion Therapeutics (Subject)
Biomotion Sciences (Subject)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Form 425
07/17/2024
8:06 AM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form 424B3
07/16/2024
11:15 PM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form EFFECT
07/12/2024
3:21 PM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form S-4/A
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
07/05/2024
2:49 PM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form S-4/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLXN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners